
Ania Moradkhani is a board-certified oncology nurse practitioner at Cancer Center of Southern California. She provides ongoing patient management and coordination of care within a highly specialized oncology setting.
Ania is an integral member of the center’s cancer research team. She has been working with Dr. Sant Chawla for over nine years as part of a multidisciplinary team caring for patients with complex solid tumor malignancies.
She is fluent in English and Armenian.
- Nurse Practitioner, Cancer Center of Southern California
- Nurse Practitioner, Sarcoma Oncology Research Center
- Registered Nurse, Marlborough Hills Rehabilitation
- Phlebotomist and Medical Assistant, Khalili Center for Bariatric Care
- Masters of Science in Nursing - Family Nurse Practitioner, University of Massachusetts, Worcester, MA
- Bachelor of Arts in Communications, California State University, Los Angeles, CA
- Family Nurse Practitioner License
- DEA Controlled Substance License
- California Registered Nurse (RN) License
- Advanced Cardiovascular Life Support (ACLS)
Ania collaborates with a team of oncologists to deliver coordinated, high-level care to a diverse oncology patient population. She is responsible for ongoing disease monitoring, coordinating and reviewing imaging studies, and guiding patients through treatment decisions based on clinical urgency.
In addition to her clinical responsibilities, she supports the operational and administrative functions of the practice, helping maintain efficiency within a high-volume, research-driven oncology environment.
Ania is actively involved in cancer research as a sub-investigator on multiple domestic and international pharmaceuticals in various therapies.
Her research responsibilities include direct participation in trial-related procedures, such as administering investigational treatments, performing skin biopsies, and supporting intrathecal chemotherapy delivery.
She has co-authored peer-reviewed oncology publications in leading medical journals. Her work contributes to the ongoing evaluation and development of emerging cancer therapies, particularly within sarcoma and other advanced malignancies.
For an appointment with our providers, please call us at 310-552-9999 or request an appointment online.


